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A B S T R A C T
Objective: To assess the association between chronic degenerative diseases and functional 
decline, cognition, and mortality prediction. 
Methods: A cross-sectional study was conducted in a geriatrics service in Belo Horizonte, 
Brazil, involving 424 patients subdivided into two groups: control and dementia. The study 
analyzed socio-demographic and environmental data, chronic degenerative diseases, the 
Charlson index, and data on functional and cognitive dementia. 
Results: After a univariate analysis, there was a greater frequency of cerebrovascular accident 
(CVA), urinary incontinence, constipation, and sleep disorder in the dementia group, while 
the multivariate analysis showed a greater number of environmental factors and sleep 
disorder. Regarding the Mini Mental State Examination (MMSE), patients with chronic 
obstructive pulmonary disease (COPD), CVA, and heart failure presented lower scores. There 
was a greater score in the dementia group with regarding the Charlson index. 
Conclusion: These comorbidities were associated with the functional decline in elderly people 
with dementia.
© 2012 Elsevier Editora Ltda. 
Doenças crônicas, cognição, declínio funcional e Índice de Charlson 
em idosos com demência
R E S U M O
Objetivo: Este estudo avaliou a associação entre as doenças crônico-degenerativas e o declínio 
funcional, a cognição e a predição da mortalidade. 
Métodos: Um estudo transversal foi realizado em um Serviço de Geriatria em Belo Horizonte, 
Brasil, envolvendo 424  pacientes subdivididos em dois grupos: controle e com demência. 
Foram analisados dados sociodemográficos e ambientais, doenças crônicas degenerativas, o 
Índice de Charlson, dados sobre a demência, funcionais e de cognição. 
Palavras-chave:
Demência
Comorbidade
Idoso
Deficiência
Doença crônica
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Resultados: Após análise univariada, houve maior frequência de acidente vascular encefálico 
(AVE), incontinência urinária, constipação intestinal e distúrbio do sono no grupo demência, 
enquanto na análise multivariada houve maior número de fatores ambientais e distúrbio 
do sono. Quanto ao Mini Exame do Estado Mental (MEEM), pacientes com doença pulmonar 
obstrutiva crônica (DPOC), AVE e insuficiência cardíaca apresentaram escores mais baixos. 
Em relação ao Índice de Charlson, houve maior pontuação no grupo com demência. 
Conclusão: As comorbidades foram associadas ao declínio funcional nos idosos com demência.
© 2012 Elsevier Editora Ltda. 
Introduction
The aging process causes significant changes in morbimortality 
patterns. Elderly people face the impact of chronic degenerative 
diseases, their consequent fragility, and their feared 
dependence, caused especially by dementia syndromes.1
Among the main causes of dementia, Alzheimer’s disease 
(AD), which is responsible for 50  to 60% of the cases, is 
highlighted. Currently, it is estimated that over 35 million 
individuals across the world suffer from the disease, and its 
prevalence has been significantly increasing in different age 
groups. In the USA, it became the fourth leading cause of death 
in the age group between 75 and 84 years old, and the third 
largest single cause of incapacity and mortality.2,3 In Brazil, it 
is estimated that approximately 700,000 people suffer from 
the disease. In this context, AD became an important public 
health problem around the world, together with vascular 
dementia (VD), addressed in most epidemiological studies. 
However, there is no consensus yet on its pathophysiological 
mechanism.4-6 Mixed dementia is a condition in which AD and 
VD occur simultaneously, with combined neurodegenerative 
and cerebrovascular changes, respectively, causing higher 
functional impairment.6,7
Elderly people with dementia present a high prevalence 
of comorbidities,8-12  which may impair cognition and 
increase functional decline, requiring early interventions 
to improve the quality of life of these patients and their 
family members, considering the functional improvement 
and maintenance of their independence for activities of daily 
living (ADLs).13-15
Objective
This work aimed to assess chronic degenerative diseases, such 
as cardiovascular, respiratory, urological, digestive, endocrine, 
and metabolic diseases, and to associate them with cognition, 
functional factors, and the Charlson’s comorbidity index (CCI) 
in elderly patients with dementia.
Methods
This was a cross-sectional study with a comparison group 
(control), using frequencies, percentages, and measures 
of central tendency and dispersion, performed in a center 
specialized in elderly care under the Brazilian Unified Health 
System (Sistema Único de Saúde – SUS), receiving patients 
from primary care. The study was performed between 2007 and 
2010 and involved 814 elderly patients with complaints of 
cognitive changes, or changes observed by their caregiver. 
Of these, 22 patients refused to sign the informed consent, 
56 provided insufficient data, 16  showed other types of 
dementia, and 296 patients with depression were excluded. 
All criteria for depression and dementia were observed in 
accordance with the Diagnostic and Statistical Manual of 
Mental Disorders, fourth edition (DSM-IV). Regarding dementia, 
the diagnosis of AD (probable or possible) was made pursuant to 
the criteria established by the National Institute of Neurological 
and Communicative Disorders and Stroke-Alzheimer’s Disease 
and Related Disorders Association (NINCDS-ADRDA), or when 
showing signals suggestive of VD through evaluation by the 
Hachinski ischemic scale, original version or as modified 
by Loeb.16-18  Elderly patients not presenting dementia 
syndrome, mood disorder, or mild cognitive impairment were 
placed in the control group. Therefore, 312 elderly people 
with dementia (VD, mixed, and AD) and 112 controls were 
studied. Information about this service is also found in other 
works.19,20 Elderly patients were evaluated pursuant to the 
Multidimensional Assessment Protocol for the Elderly. This 
procedure is described in the Guide for Health Care of the 
Elderly (Linha Guia de Atenção a Saúde do Idoso) of the Minas 
Gerais State Department of Health.21 This study was approved 
by the local ethics committee.
The study variables were demographics, valid functional 
assessment scales,22,23 Mini Mental State Examination (MMSE), 
data on dementia (Clinical Dementia Rating [CDR]24 and 
Behavioral and Psychological Symptoms of Dementia [BPSD]), 
and CCI.25
The instruments used were selected to address the main 
clinical dimensions potentially associated with the existence 
of comorbidities. The following conditions were evaluated: 
osteoarthritis, osteoporosis, malignant neoplasia, systemic 
arterial hypertension (SAH), congestive heart failure (CHF), 
atrial fibrillation, chronic coronary artery disease, anemia, 
diabetes mellitus, chronic obstructive pulmonary disease 
(COPD), cerebrovascular accident (CVA), dyspepsia, vitamin 
B12 deficiency, folic acid deficiency, urinary incontinence, 
constipation, hypothyroidism, liver disease, dyslipidemia, 
hyperuricemia, chronic renal failure, peripheral arterial 
and venous insufficiency, immobility syndrome, postural 
instability, falls, fractures, and sleep disorders.
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The following additional examinations were part of the 
propedeutics in patients attended to at the reference center: 
complete blood count, thyroid-stimulating hormone (TSH), 
vitamin B12, folic acid, fasting glucose, urea, creatinine, 
total cholesterol and fractions, triglycerides, uric acid, 
sodium, potassium, chloride, calcium, phosphorus, alkaline 
phosphatase, albumin, globulins, urine test, fecal occult 
blood test, chest X-ray, and electrocardiogram. The rhythm 
of glomerular filtration was calculated by the Crockoft-Gault 
equation. Other additional examinations were requested 
according to the clinical indication. Computed tomography 
or magnetic resonance imaging was performed in all patients 
with VD or mixed dementia.
The CCI was originally designed as a measure of mortality 
risk within a year attributable to comorbidity in a longitudinal 
study. It was then validated in a cohort of breast cancer female 
patients. Its contents and weighting scheme were created 
based on Cox’s proportional hazards model.25
Information collected was entered into a database 
developed using Access® 2007 software. Subsequently, data 
was analyzed in R, version 2.7.1– a public domain software.
The descriptive results were obtained using frequencies 
and percentages for the characteristics of the categorical 
covariates, and by obtaining measures of central tendency 
(mean and median) and dispersion (standard deviation) for the 
quantitative variables. The variables (control and dementia) 
and categorical covariates were compared through contingency 
tables, and the Yates-corrected chi-squared test was applied 
to compare proportions when there were two categories in 
each variable. When the number of categories was higher than 
two, the Pearson’s chi-squared test was used. If at least one 
expected frequency was lower than five, Fisher’s exact test was 
used. To compare the quantitative variables and covariates, 
Student’s t-test was used when the usual assumptions for the 
model were met. Otherwise, the Mann-Whitney test was used. 
The assumptions for the Student’s t-test were verified using 
the Shapiro-Wilk test and Levene’s test.
Results
Family and caregivers reported that the time between the 
changes observed in the individuals and the diagnosis of 
dementia averaged 27.6 months, and 33.9 months for the 
beginning of the specific treatment with anticholinesterase 
for AD.
The demographics are presented in Table 1, and they 
demonstrate a similarity between the groups. A higher number 
of drugs were evidenced in the dementia group, reflecting a 
higher number of comorbidities.
The result of the univariate analysis is presented in 
Tables 1 and 2, and demonstrates that both groups had a 
Characteristics Group p-value OR 95% CI 
Dementia Control
 n % n %    
Gender
 Female 209 71.8 82 28.2 0.271a 0.7 0.4 to 1.2
 Male 103 77.4 30 22.6 1.0
Education
 0 to 4 years 265 75.5 86 24.5 0.039b 6.2 0.9 to 49.3
 5 to 8 years 24 61.5 15 38.5 3.2 0.4 to 29.3
 9 to 11 years 18 72.0 7 28.0 5.1 0.6 to 54.1
 Over 12 years 2 33.3 4 66.7 1.0
Age
 Up to 64 years 7 87.5 1 12.5 0.456b 2.8 0.1 to 107.3
 65 to 74 years 76 67.3 37 32.7 0.8 0.1 to 5.1
 75 to 84 years 150 75.4 49 24.6 1.2 0.2 to 7.4
 85 to 94 years 74 76.3 23 23.7 1.3 0.2 to 8.3
 Over 95 years 5 71.4 2 28.6 1.0
Marital status
 Married 165 74.7 56 25.3 0.287b 1.0 0.6 to 1.7
 Divorced 16 84.2 3 15.8 1.8 0.5 to 8.3
 Single 21 61.8 13 38.2 0.5 0.2 to 1.3
 Widow(er) 95 74.8 32 25.2 1.0
Medicines (more than 5 classes)
 Yes 126 92.0 11 8.0 < 0.001a 6.2 3.1 to 12.7
 No 186 65.0 100 35.0  1.0  
95% CI, 95% confidence interval; OR, odds ratio.
aYates-corrected test.
bFisher’s exact test.
Table 1 – Comparison between the socio-demographic characteristics and the use of medication between patients with 
dementia and the control group in a population of elderly people, Belo Horizonte, Brazil. 2007 to 2009.
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high prevalence of chronic diseases. There was a statistically 
significant difference for sleep disorders, CVA, constipation, 
and urinary incontinence, which were most prevalent in the 
dementia group.
Using a multivariate logistic regression analysis, sleep 
disorders were more frequent in the dementia group (OR: 4.4; 
CI: 1.4 to 13.4).
Regarding CCI, there was a difference, with higher score in 
the dementia group, which averaged 5.5 (p < 0.001).
The number of psychosocial factors occurring in the last five 
years was found to be correlated, in this study, to the diagnosis 
of dementia. The main psychosocial stressors were loss of the 
partner (widowhood), onset of diseases, disability, and disease 
in a close relative.
Regarding the MMSE, the associations found, regardless of 
the group, are described in Tables 3 and 4. There was a direct 
association between the MMSE score, education level, and the 
number of environmental factors; an inverse association was 
observed with age, drugs and CCI.
Regarding the comorbidities, COPD, CVA, and heart failure 
presented a lower score in the MMSE, regardless of the group. 
As expected, cognition showed worse results when associated 
with functional dependence.
Characteristics Group p-value OR 95% CI 
Dementia Control
 n % n %    
Sleep disorders
 Yes 187 91.7  17 80.3 < 0.001* 8.4 4.6 to 15.3
 No 125 56.8  95 43.2 1.0
Constipation
 Yes  68 86.1  11 13.9 0.009* 2.5 1.2 to 5.3
 No 244 70.9 100 29.1 1.0
CVA
 Yes  48 85.7   8 14.3 0.041* 2.4 1.03 to 5.6
 No 264 71.7 104 28.3 1.0
Urinary incontinence
 Yes  68 90.7   7 90.3 < 0.001* 4.2 1.8 to 10.3
 No 243 70 104 30.0 1.0
SAH
 Yes 225 74.3  78 25.7 < 0.708* 1.1 0.7 to 1.9
 No  87 71.9  34 28.1 1.0
Hyperlipidemia
 Yes  87 74.4  30 24.4 0.920* 1.1 0.6 to 1.8
 No 225 73.3  82 26.7 1.0
Vitamin B12 deficiency
 Yes  80 78.4  22 21.6 0.252* 1.4 0.8 to 2.5
 No 232 72.1  90 27.9 1.0
Osteoporosis
 Yes  74 71.8  29 28.2 0.797* 0.9 0.5 to 1.4
 No 228 73.8  81 26.2 1.0
Postural instability
 Yes 104 79.4  27 20.6 0.100* 1.6 0.9 to 2.6
 No 208 71.2  84 28.7  1.0  
95% CI, 95% confidence interval; CVA, cerebrovascular accident; OR, odds ratio; SAH, systemic arterial hypertension.
*Yates-corrected test. 
Table 2 – Comparison of the characteristics related to the main comorbidities between patients diagnosed with 
dementia and a comparative group in a population of elderly people, Belo Horizonte, Brazil. 2007 to 2009.
Characteristics Correlation 
coefficient
p-value
Age (years) −0.214 < 0.001*
Education (years) 0.268 < 0.001*
Number of environmental factors 0.118 0.002*
Number of medicines −0.134 0.001*
CCI −0.400 0.001*
CCI, Charlson comorbidity index.
*Spearman’S correlation coefficient.
Table 3 – Comparison between the quantitative 
variables and the Mini Mental State Examination 
in a population of elderly people, Belo Horizonte, 
2007 to 2009.
Discussion
Elderly show a high prevalence of chronic diseases. This study 
aimed to address the most prevalent dysfunctions that can 
impact the lives of the individuals and their families.
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The most frequent comorbidities were SAH (74.3%), sleep 
disorders (48.3%), and dyslipidemia (28.9%), and they were 
similar to those found in outpatient clinics in patients aged 
60 years or older.26,27 In the studied population, there was 
a higher prevalence of comorbidities in the dementia group 
compared to the control group.
Urinary incontinence was more frequent among older 
patients with dementia, which is consistent with data found 
in other studies. Ko, et al.,28 when studying a random sample 
of elderly people, observed that 25% of the individuals had 
difficulty in controlling their urine. Of these, 30% were older 
than 75 years. It must be highlighted that urinary incontinence 
leads to stigmatization and social isolation, is associated with 
depressive symptomatology, and is often neglected in the 
literature.28
Postural instability, also frequent in this study, is associated 
with balance dysfunction and results in risk of fall, but 
the physical and psychosocial sequelae of the excessive 
reduction in movements may be more detrimental than the 
fall itself.29 This fact is probably related to the inclusion of 
individuals with advanced dementia, functional impairment, 
more frequent use of medicines, and high prevalence of 
falls.30-32
Constipation was associated with the dementia group, 
higher dependence regarding instrumental ADLs, CVA, urinary 
incontinence, and postural instability. This fact possibly results 
from the restricted mobility, the use of antidepressants, and 
the lack of physical activities. Constipation is also part of the 
iatrogenic cascade that may result in higher functional decline 
and deterioration in quality of life of the elderly people, as 
there is a need of more drugs and more daily care, making the 
role of the caregiver even more difficult.33
Folate (3.5%), vitamin B12 (23.6%), and anemia (6.2%) 
deficiencies were similar to other Brazilian studies,34,35 and 
may be associated with nutritional factors and/or with the 
use of medications that may interfere with the absorption of 
nutrients.
Regarding renal function, it is known that the best method, 
even with all limitations for its evaluation, is to determine 
the glomerular filtration rate. This method is influenced by 
several factors, such as age and muscle mass.36 This data is 
not emphasized because of the prevalence of renal changes 
(8.6%), but because of its iatrogenic potential, especially in 
people with dementia, as this group used a higher number 
of drugs and classes of drugs compared to the control group 
(median = 5 drugs; 6.2 times higher chance of using more than 
five different classes of drugs in comparison with the control 
group, with p < 0.01).
Researches showed differences in the type of comorbidity 
when comparing elderly people with dementia to control 
groups. Among them, in VD, a lower prevalence of CHF 
and higher prevalence of diabetes mellitus must be 
highlighted.37
Differences regarding the comorbidities among patients 
with or without dementia were not found in the literature. 
However, methodological differences make comparisons 
Model Coefficient 95% CI Standard error p-value
  Inferior Superior   
Constant 29.1 1.5 < 0.001
Education
 More than 12 years
 9 to 11 years −1.1 −4.2 2.0 1.6 0.491
 5 to 8 years −0.8 −3.7 2.1 1.5 0.612
 0 to 4 years
COPD
 Yes −3.2 −6.1 −0.3 1.5 0.031
 No −1.1 −2.1 −0.1 0.5 0.049
CVA
 Yes −1.9 −2.9 −0.9 0.5 < 0.001
 No
Heart failure
 Yes −1.7 −2.9 −0.5 0.6 0.003
 No
Basic ADLs
 Dependent −1.1 −2.1 −0.1 0.5 0.045
 Partially dependent −9.2 −11.0 −7.4 0.9 < 0.001
 Independent
Instrumental ADLs
 Dependent −1.7 −2.7 −0.7 0.5 < 0.001
 Partially dependent −3.0 −4.4 −1.6 0.7 < 0.001
 Independent      
95% CI, 95% confidence interval; ADLs, activities of daily living; COPD, chronic obstructive pulmonary disease; CVA, cerebrovascular accident.
Table 4 – Final model of linear regression for the Mini Mental State Examination variable in a population of elderly 
people, Belo Horizonte, 2007 to 2009.
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difficult.11 Zhu et al.,38 in a study conducted with 180 patients 
with dementia, observed that half of them presented no 
comorbidities.
Few studies were performed with populations of elderly 
people with cognitive changes in Brazil. The existing studies 
are based on population studies, with analysis of self-reported 
diseases, or on cross-sectional observational studies. 
However, even in larger cohorts, there is a diagnostic bias on 
several specific conditions of the elderly, and the functional 
assessment is frequently neglected.39 One of the difficulties in 
carrying out these studies is the time necessary for the correct 
diagnosis, with proper propedeutics, which can take weeks or 
months. Duarte and Rego,34 in a study conducted in a geriatrics 
service, where depression and dementia were evaluated as 
comorbidities, found 95% of the individuals to have at least 
one chronic disease, mainly: SAH (62.2%), osteoarthritis (40%), 
and urinary incontinence (35%). These data were similar to the 
comorbidities found in this study.
It is likely that the comorbidities in patients with cognitive 
impairment are usually underdiagnosed and mistreated, 
possibly because patients with dementia show greater difficulty 
in objectively complaining about their issues.40-42 Formiga et 
al.27 found a prevalence of 51% of SAH in a cohort of patients 
with AD. Artza et al.,42 observed a prevalence of 45% for this 
population. Schubert et al.11 found a prevalence of 39% in a 
study conducted in patients with an average age of 75.6 years 
and diabetes mellitus.
Regarding several chronic diseases prevalent in elderly 
people with dementia, their percentages showed to be similar 
to those described in the literature, such as heart failure (14%), 
COPD (12.2%), osteoarthritis (41.1%), CVA (10.3%), and cancer 
(12%).11 It is likely that these percentages vary according to the 
clinical diagnoses and the availability of autopsy. Fu et al.,9 in 
a study conducted with 52 patients diagnosed with all types 
of dementia, and with availability of autopsy, evidenced 20% 
coronary artery disease, and 73% atherosclerotic cardiovascular 
disease.
An indirect way of verifying the presence of chronic 
comorbidities is to quantify medicines. In a study performed 
with 311 patients with dementia aged 64 years and older, 
Formiga et al.27 found an average of six medicines, similar 
to that found by Lyketsos et al.40 in a study conducted with 
149 patients with dementia. Schubert et al.11 found an average 
of 5.1 medicines in their studies. Also regarding the studies 
performed by Formiga et al.,27  the percentage of 70% of 
patients with a chronic disease who take five medicines or 
more must be emphasized. Confirming this data, the present 
study showed an average of four medicines for the control 
group and an average of five medicines for the dementia and 
depression groups, which were not distinguished by class. 
When differentiating by class, there was a difference between 
the dementia and control groups (OR: 6.2; CI: 3.1-12.7).
In the present study, there was a statistically significant 
difference in the CCI between the groups, and this index was 
higher in the dementia group. Dementia is an item of the CCI; 
therefore, the score was not considered in the analysis of the 
groups. Thus, it can be concluded that dementia is a major 
impact factor on morbimortality of the elderly population, 
which is consistent with other studies.11,25,39 In this study, the 
age-adjusted CCI was used. Thus, the index was higher in the 
dementia group, indicating not only a higher number, but also 
more severe comorbidities in the population, even excluding 
the dementia factor from the index.
The average of the MMSE in the study population 
diagnosed with dementia was 13, and the CCI was equal to 
5.8, higher than that in the control group (4.3). It must be 
highlighted that the high number of comorbidities in the 
study population, together with their severity, may have 
influenced this data.
Artza et al.,42  in a study performed in France with 
579 patients with AD with an average age of 77.4 years and 
average MMSE score of 20.1, quantified the comorbidity with 
the non-age-adjusted CCI, showing an average of 1.5.
Formiga et al.27 found, in patients with VD, an average age 
of 80.6 years, average MMSE score of 13.7, and comorbidities 
quantified by the CCI with an average of 2.1 VD.
Doraiswamy et al.39 when evaluating 679 patients with AD 
of age and severity similar to those of the present study, found 
an average MMSE score of 11.8, however, not using the CCI; 
thus, not allowing for comparisons between the comorbidities.
Comparison between the dementia and control groups
Dementia should not be diagnosed late, as happens in many 
parts of the world.38-41 A better understanding of the clinical 
manifestations, genetic basis, and molecular biology of the 
disease, as well as an improved definition of its pathogenesis, 
may contribute to the proper treatment of cases.6 This study 
registered, for dementia, a long interval between the changes 
observed by the individuals and their family members and the 
diagnosis (median of 46 months), and the specific treatment 
with anticholinesterase (median of 48 months). This fact is 
possibly associated with the difficulty of access of patients to 
qualified professionals for the proper diagnosis of the disease. 
Even with recall bias, the beginning of the treatment was also 
late, considering the use of specific medicines to treat the 
disease.
Among the social and demographic factors related to the 
diseases, after a multivariate analysis, low education was 
associated with dementia diagnosis. Despite the existing 
controversies between different studies, Caamaño-Isorna 
et al.43 showed, in a meta-analysis, that a low education 
level may be a risk factor for dementia, especially for AD. 
Individuals showing high cognitive reserve, which results 
from higher education, have an increased capacity to 
maintain their cognitive skills, regardless of neuropathological 
changes.44 Education results in higher cognitive reserve 
through more complex education and labor activities, and 
triggers changes in lifestyle that allow for a reduction in the 
risk of brain damage – reduction in alcohol consumption 
and smoking, improved diet, and practice of physical 
activities.45 Thus, low education level may result in a risk 
factor for dementia, especially in developing countries, where 
low education level is a frequent issue.
This study showed no association between smoking and 
dementia (p = 0.907), in disagreement with the literature. 
Cataldo, Prochaska, and Glantz,46 through meta-analysis, 
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conducted studies that investigated the relationship between 
smoking and dementia. Their results demonstrated that, in 
cohort studies not sponsored by the tobacco industry, the 
average risk of AD, determined by smoking, was estimated at 
1.72. These data indicate that smoking is a major risk factor 
for the disease.
The changes observed regarding functional decline 
and the MMSE were significant in the group of individuals 
with dementia. CDR was descriptively analyzed for the 
population with dementia. The majority of the patients with 
dementia presented a CDR score of 1 or 2 (87.3%), i.e., mild 
or moderate dementia. This favors the reliability of clinical 
data in comparison with other groups, as it is difficult to 
obtain information for accurate diagnoses in advanced stage 
dementia, due to the inability to communicate.47
By analyzing the sample of patients with AD only, it was 
observed that the occurrence of BPSD (43.7%) is consistent 
with the literature.48 It was also noted that, in this group, 
the number of women was higher than the number of 
men, resulting from the higher prevalence of the disease 
among women, their higher survival rate in comparison 
to men, and their higher demand for health services, 
with increased diagnosis rates.49 This factor relates to 
the high use of antipsychotics and antidepressants in this 
population.
Gill et al.50 demonstrated a higher mortality in elderly 
people with dementia using antipsychotics, with an increased 
risk for conventional antipsychotics when compared with 
atypical antipsychotics. Therefore, they must be used 
carefully.
In the present study, both BPSD and depressive 
symptomatology itself may explain the association between 
sleep disorders and dementia (OR = 8.4, CI = 4.6-15.3), when 
comparing the dementia group with the control group.
After comparing the dementia group with the control 
group, a worse score in the MMSE was observed when the 
following characteristics were present: COPD, CVA, CHF, and 
deterioration in ADLs.
When separating the dementia group into dementia 
associated with depression and dementia only, a lower 
score was observed in the MMSE for the dementia group 
in comparison with the dementia group associated with 
depression, even when the other variables were controlled. 
This contradicts the literature, suggesting that depression 
associated with dementia affects cognition.51,52 Thus, the 
MMSE may not have been sufficient to detect this change.
Regarding urinary incontinence, the MMSE showed a 
lower score in the multivariate analysis, with tendency for 
statistical significance (p = 0.056), probably related to more 
severe dementia and depression cases associated with changes 
in mobility. The possibility that the association between 
the MMSE and depression is due to the cause and effect of 
cognitive deterioration is highlighted.
Conclusion
The present study reinforced the need to approach the 
elderly person as a whole, especially those with dementia, 
who are fragile, have high prevalence of comorbidities, and 
use a large number of medicines. A careful evaluation may 
detect highly relevant clinical conditions that may change 
individuals’ cognition and level of dependence, as well as 
influence their mortality, regardless of the development of 
dementia itself.
Elderly patients may develop dementia that may be 
associated with chronic diseases (mainly COPD, CVA, and 
heart failure), as evidenced in this study. A correct approach 
to these diseases may contribute to a cognitive and functional 
improvement for elderly people. Other studies may confirm 
this hypothesis.
The use of a specific medication for dementia should be 
associated with an indication of comorbidities. Accordingly, 
accuracy in prescribing drugs may help to improve and 
adapt the indication of anticholinesterase and glutamatergic 
drugs, anticipating side effects and interactions with other 
medications.
The results found may be useful to the physicians that 
attend to elderly patients, as they may provide information for 
approaching multiple conditions, requesting additional tests 
and polypharmacy for these patients, and contributing to a 
better quality of life for these individuals and their families.
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